MOMENTAN AUSVERKAUFT
Über dieses Produkt
Product Identifiers
PublisherBasic Books
ISBN-101560256974
ISBN-139781560256977
eBay Product ID (ePID)44674503
Product Key Features
Number of Pages352 Pages
Publication NameSelling Sickness : How the World's Biggest Pharmaceutical Companies Are Turning Us All Into Patients
LanguageEnglish
SubjectEthics, Industries / Pharmaceutical & Biotechnology, General, Caregiving
Publication Year2005
TypeTextbook
AuthorRay Moynihan, Alan Cassels
Subject AreaBusiness & Economics, Medical
FormatHardcover
Dimensions
Item Height0.9 in
Item Weight14.5 Oz
Item Length9 in
Item Width6 in
Additional Product Features
Intended AudienceTrade
LCCN2006-272734
Dewey Edition22
Dewey Decimal381.456151
Edition DescriptionAnnotated edition
SynopsisThirty years ago, Henry Gadsden, the head of Merck, one of the world's largest drug companies, told Fortune magazine that he wanted Merck to be more like chewing gum maker Wrigley's. It had long been his dream to make drugs for healthy people so that Merck could "sell to everyone." Gadsden's dream now drives the marketing machinery of the most profitable industry on earth. Drug companies are systematically working to widen the very boundaries that define illness, and the markets for medication grow ever larger. Mild problems are redefined as serious illness and common complaints are labeled as medical conditions requiring drug treatments. Runny noses are now allergic rhinitis, PMS has become a psychiatric disorder, and hyperactive children have ADD. When it comes to conditions like high cholesterol or low bone density, being "at risk" is sold as a disease. Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits, in turn threatening to bankrupt health-care systems all over the world. As more and more of ordinary life becomes medicalized, the industry moves ever closer to Gadsden's dream: "selling to everyone.", Thirty years ago, the head of the drug company Merck made some remarkably candid comments about his distress that his company's market was limited to sick people. Suggesting he would like Merck to be more like the maker of Wrigley's chewing gum, the CEO said it had long been his dream to make drugs for healthy people, to "sell to everyone." That dream now drives the marketing machinery of the most profitable industry on earth. From award-winning Ray Moynihan, -one of the world's top medical journalists-Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits. This in turn is driving up personal drug bills and threatening to bankrupt national health systems all over the world. As more and more ordinary life is "medicalized," the industry moves ever closer to being able to "sell to everyone.", Ray Moynihan--one of the world's top medical journalists--reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits for the giant pharmaceutical companies., Thirty years ago, the head of the drug company Merck made some remarkably candid comments about his distress that his company's market was limited to sick people. Suggesting he would like Merck to be more like the maker of Wrigley's chewing gum, the CEO said it had long been his dream to make drugs for healthy people, to "sell to everyone." That dream now drives the marketing machinery of the most profitable industry on earth. From award-winning Ray Moynihan,--one of the world's top medical journalists--Selling Sickness reveals how widening the boundaries of illness and lowering the threshold for treatments is creating millions of new patients and billions in new profits. This in turn is driving up personal drug bills and threatening to bankrupt national health systems all over the world. As more and more ordinary life is "medicalized," the industry moves ever closer to being able to "sell to everyone."
LC Classification NumberHD9665.5.M69 2005
Bewertungen und Rezensionen
Relevanteste Rezensionen
- 29. Jan. 2019
Not keeping my attention
Boring boring boring. Was expecting something different. This book goes straight into a few drugs and how the market is ran by people paid by pharmaceutical companies. Something we all already know. Just not an interesting readBestätigter Kauf: JaArtikelzustand: Gebraucht
